Ezetimibe Azetidinone Ring opened impurity arises from the cleavage of the four-membered azetidinone core in ezetimibe, resulting in a linearized structure retaining the (4-fluorophenyl)amino moiety and the 2-oxoethyl side chain. The ring-opening introduces an exocyclic amino group conjugated to a ketone, disrupting the parent drug's lactam scaffold. This impurity features a fluorinated aromatic ring, an ether linkage, and a terminal carboxylic ester, maintaining key pharmacophoric elements while altering stereochemical constraints. It serves as an HPLC reference standard for quantifying process-related impurities in ezetimibe active pharmaceutical ingredient synthesis.
On Request1618657-29-6
C1=CC(=CC=C1[C@H]([C@@H](CC[C@@H](C2=CC=C(C=C2)F)O)C(=O)O)NC3=CC=C(C=C3)F)O
InChI=1S/C24H23F2NO4/c25-17-5-1-15(2-6-17)22(29)14-13-21(24(30)31)23(16-3-11-20(28)12-4-16)27-19-9-7-18(26)8-10-19/h1-12,21-23,27-29H,13-14H2,(H,30,31)/t21-,22+,23-/m1/s1
XGNDFEVQHMNNOJ-XPWALMASSA-N